Search results

The study was partially funded by the "Accion Transversal del Cancer", approved on the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER, a way to build Europe (PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-León, PI09/01903-Valencia, PI09/02078-Huelva, PI09/ 01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613), by the Fundación Marqués de Valdecilla (API 10/09), by the ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)), by the Consejería de Educación, Junta de Castilla y León (LE22A10-2), by the Consejería de Salud, Junta de Andalucía (2009-S0143), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the Recercaixa (2010ACUP 00310), by the Regional Government of the Basque Country, by the Consejería de Sanidad y Política Social, Comunidad Autónoma de la Región de Murcia, by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Scientific Foundation, Spanish Association Against Cancer (AECC), by the Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723, by the Fundación Bancaria Caja de Ahorros de Asturias and by the University of Oviedo. ; Vallès, X., Alonso, M.H., López-Caleya, J.F., Díez-Obrero, V., Dierssen-Sotos, T., Lope, V., Molina-Barceló, A., Chirlaque, M.D., Jiménez-Moleón, J.J., Fernández Tardón, G., Castilla, J., Amiano, P., Capelo, R., Castaño-Vinyals, G., Guinó, E., Molina de la Torre, A.J., Moreno-Iribas, C., Pérez Gómez, B., Aragonés, N., Llorca, J., Martín, V., Kogevinas, M., Pollán, M., Moreno, V.

Biological samples were stored at the biobanks supported by Instituto de Salud Carlos III- FEDER: Parc de Salut MAR Biobank (MARBiobanc) (RD09/0076/00036), 'Biobanco La Fe' (RD 09 0076/00021) and FISABIO Biobank (RD09 0076/00058), as well as at the Public Health Laboratory of Gipuzkoa, the Basque Biobank, the ICOBIOBANC (sponsored by the Catalan Institute of Oncology), the IUOPA Biobank of the University of Oviedo, and the ISCIII Biobank. SNP genotyping services were provided by the Spanish 'Centro Nacional de Genotipado' (CEGEN-ISCIII). We thank all the subjects who participated in the study and all MCC-Spain collaborators. This work was supported by the 'Accion Transversal del Cancer', approved by the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III, co-founded by FEDER funds-'a way to build Europe' (grants PI08/1770, PI08/0533, PI08/1359, PI09/00773, PI09/01286, PI09/01903, PI09/02078, PI09/01662, PI11/01403, PI11/01889, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/00613, and PI15/00069). Support was also provided by the Fundación Marqués de Valdecilla (grant API 10/09); the Junta de Castilla y Leon (grant LE22A10-2); the Consejería de Salud of the Junta de Andalucía (2009-S0143); the Conselleria de Sanitat of the Generalitat Valenciana (grant AP 061/10); the Recercaixa (grant 2010ACUP 00310); the Regional Government of the Basque Country; the Consejería de Sanidad de la Región de Murcia; European Commission grants FOOD-CT-2006-036224-HIWATE; the Spanish Association Against Cancer (AECC) Scientific Foundation; the Catalan Government DURSI (grant 2014SGR647); the Fundación Caja de Ahorros de Asturias; the University of Oviedo; Societat Catalana de Digestologia; and COST action BM1206 Eucolongene. ; Ibáñez-Sanz, G., Diéz-Villanueva, A., Alonso, M.H., Rodríguez-Moranta, F., Pérez-Gómez, B., Bustamante, M., Martin, V., Llorca, J., Amiano, P., Ardanaz, E., Tardón, A., Jiménez-Moleón, J.J., Peiró, R., ...